Skip to main content
. 2015 Jun;35(7):563–578. doi: 10.1177/0333102414552532

Table 4.

Distribution of respondents with episodic (EM) and chronic migraine (CM) by study module.

Time of emailing Module(s) EM respondents, n (%) CM respondents, n (%) Total respondents,a n
Month 0 (Baseline) Screening, Core (wave 1), and Barriers to Care 15,313 (91.2) 1476 (8.8) 16,789c
Month 1 (resampled in month 11)e Comorbidities/endophenotypes 11,699 (91.3) 1111 (8.7) 12,810
Month 2 (resampled in month 7)e Family Burden Module (Proband)b 11,938 (91.4) 1126 (8.6) 13,064
Month 3 Snapshot (wave 2) 9022 (92.6) 719 (7.4) 9741c
Month 3 (resampled in month 8)e Family Burden Module (Partner) 3642 (90.6) 380 (9.4) 4022
Month 4 (resampled in month 8)e Family Burden Module (Child) 1536 (88.6)d 197 (11.4)d 2140d
Month 6 Core (wave 3) 6990 (93.0) 527 (7.0) 7517c
Month 9 Snapshot (wave 4) 5956 (93.6) 406 (6.4) 6362
Month 12 Core (wave 5) 5502 (93.0) 413 (7.0) 5915c
a

Total number of respondents who completed each of these modules.

b

Family Burden Module was supplemented with additional respondents who were over quota but otherwise qualified per the CaMEO Study criteria (see Figure 2).

c

Includes those who completed each wave (Snapshot/Core Module). A subset of this population completed all 5 waves (Core/Snapshot; n = 3626).

d

The total number of children responding to the Family Burden Module (Child version) was 2140, representing 1733 unique probands. Rates of EM and CM respondents were calculated based on the number of unique probands (n = 1733), since some had multiple children respond to the survey.

e

A fraction of the sample did not complete either the Family Burden or Comorbidities/endophenotypes modules during stage 2, and were resampled during stage 3 to minimize nonresponse.